Editing P2Y12

'''P2Y12''' is a [[G protein-coupled receptor]] (GPCR) that is found on the surface of [[platelet]] cells. It is part of the [[Purinergic receptor]] family of GPCRs, which are activated by [[adenosine diphosphate]] (ADP) and [[adenosine triphosphate]] (ATP). P2Y12 plays a crucial role in the process of [[blood clotting]] and [[thrombosis]].

== Function ==

P2Y12 is primarily involved in the regulation of platelet activation and aggregation. When ADP binds to the P2Y12 receptor, it triggers a series of [[intracellular signaling]] events that result in the activation of [[glycoprotein IIb/IIIa]], a receptor that allows platelets to bind to [[fibrinogen]] and aggregate. This process is essential for the formation of a stable [[blood clot]].

== Clinical significance ==

Due to its role in platelet activation and aggregation, P2Y12 is a target for [[antiplatelet therapy]]. Drugs that inhibit the P2Y12 receptor, such as [[clopidogrel]], [[prasugrel]], and [[ticagrelor]], are used to prevent thrombosis in patients with [[coronary artery disease]], [[peripheral artery disease]], and those undergoing [[percutaneous coronary intervention]] (PCI).

== Pharmacology ==

P2Y12 inhibitors work by blocking the binding of ADP to the P2Y12 receptor, thereby preventing platelet activation and aggregation. These drugs are commonly used in the management of [[acute coronary syndrome]] (ACS) and in the prevention of [[stent thrombosis]] after PCI.

== See also ==

* [[P2Y receptor]]
* [[Platelet]]
* [[Thrombosis]]
* [[Antiplatelet therapy]]

[[Category:G protein-coupled receptors]]
[[Category:Blood]]
[[Category:Pharmacology]]
{{GPCR-stub}}
{{medicine-stub}}
{{No image}}
__NOINDEX__